Sanara MedTech Inc. (SMTI) · Oct 29, 2026 · Disposition
$2M disposition — Approximately $2.0M purchase price plus earnout rights
Sanara MedTech’s disposition sells Tissue Health Plus assets for about $2M, advancing its exit from the non-core platform and surgical refocus.
Sanara is refocusing on a pure-play surgical solutions business after moving away from Tissue Health Plus and its value-based wound-care platform.
The strategic exit is now executed, not just planned. Sanara sold all THP assets—including its business software products and related intellectual property—on October 6, 2026. That turns the previously known wind-down into a completed disposition and removes a non-core operating distraction. The direction was already visible in the company’s prior disclosures, so the surprise is mainly the transaction detail rather than the strategic decision.
The financial benefit is modest but tangible. The company received approximately $2.0 million and retained certain earnout rights. The filing does not disclose the assets’ carrying value, expected earnout amount, use of proceeds, or whether the sale produces a gain or loss, so the cash impact cannot be judged beyond the headline proceeds.
Bottom line: This is a small, partly anticipated cleanup transaction that advances Sanara’s surgical refocus. It matters more for simplifying the business than for the immediate $2 million of proceeds.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!